| 96904-8 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC:-:RptPeriod:^Patient:-:CMS Assessment | 6 |
| 96905-5 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment | 6 |
| 96906-3 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment | 15 |
| 96907-1 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment | 10 |
| 96908-9 | MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status:-:RptPeriod:^Patient:-:CMS Assessment | 64 |
| 96910-5 | Free-living amoeba Pnl Spec | 4 |
| 96911-3 | D-ALA + PBG Pnl SerPl | 3 |
| 96929-5 | Personal well-being panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 96936-0 | Person-specific outcome panel:-:Pt:^Patient:-:R-Outcomes | 3 |
| 96939-4 | Social contact panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 96945-1 | Health confidence panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 96951-9 | Social determinants of health panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 96977-4 | NIP fet aneu Pnl WBC.DNA+cfDNA | 41 |
| 96978-2 | NIP aneu + 22q11.2 Pnl WBC.DNA+cfDNA | 48 |
| 96987-3 | Mass vaccination status:-:Pt:^Event:-:CDC.EOC | 16 |
| 97023-6 | Accountable health communities health-related social needs supplemental questions:-:Pt:^Patient:-: | 18 |
| 97024-4 | aPTT Mix Pnl PPP | 9 |
| 97026-9 | PS-prothrom cmplx IgG IgM Pnl SerPl | 3 |
| 97029-3 | Spine Tango surgery f/u 2017 Spine Tango | 5 |
| 97031-9 | Spine Tango | 11 |
| 97042-6 | Complications pnl Spine Tango | 6 |
| 97055-8 | FINDRISC pnl FINDRISC | 10 |
| 97065-7 | Hx for COVID -19 vaccine | 16 |
| 97096-2 | COVID-19 experiences - media use panel:-:Pt:^Patient:-:COVEX | 21 |
| 97099-6 | FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid | 4 |
| 97123-4 | COVID-19 experiences - employment and school changes panel:-:Pt:^Patient:-:COVEX | 18 |
| 97147-3 | COVID-19 experiences - coping panel:-:Pt:^Patient:-:COVEX | 24 |
| 97161-4 | Amphetamines Pnl Ur Cfm | 13 |
| 97172-1 | Yop Ab Pnl Ser Line blot | 9 |
| 97182-0 | Carnitine + acylcarnitine Pnl SerPl | 5 |
| 97183-8 | Mephobarb + phenobarb Pnl SerPl | 3 |
| 97324-8 | CPR bact ID + resistance Pnl Islt/Spm | 13 |
| 97326-3 | SA ID + resistance Pnl Islt/Spm | 7 |
| 97327-1 | Core Outcome Measures Index for the Neck:-:Pt:^Patient:-:COMI | 18 |
| 97339-6 | Pain severity + Body site Pnl | 11 |
| 97502-9 | Prion disease biomarker panel CSF | 4 |
| 97511-0 | Fungal Ab Pnl Spec ID | 5 |
| 97533-4 | GH p glucose Pnl SerPl | 7 |
| 97535-9 | Gas Pnl BldCV | 21 |
| 97557-3 | AGID Ab pnl Ser | 9 |
| 97561-5 | Necrotizing myopathy Ab pnl Ser | 6 |
| 97564-9 | ANA pnl Ser | 11 |
| 97566-4 | MG and LES Ab Pnl Ser | 6 |
| 97593-8 | Lymph T + B-cell + NK subsets Pnl L Resp | 8 |
| 97602-7 | GFAP + UCH-L1 Pnl Plas | 4 |
| 97608-4 | Joint pathogens Pnl Snv NAA+n-prb | 40 |
| 97733-0 | FLUAV + FLUBV + subtyp Pnl Spec NAA+prb | 22 |
| 97759-5 | Mg+Phos+Lact Pnl SerPl | 4 |
| 97782-7 | Spine Tango Surgery 2017 | 7 |
| 97783-5 | Admission/path pnl Spine Tango | 3 |